Related references
Note: Only part of the references are listed.Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
Role of tyrosine phosphorylation in modulating cancer cell metabolism
Maria Letizia Taddei et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Long Noncoding RNA LINC00551 Suppresses Glycolysis and Tumor Progression by Regulating c-Myc-Mediated PKM2 Expression in Lung Adenocarcinoma
Li Wang et al.
ONCOTARGETS AND THERAPY (2020)
Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer
Nan Jin et al.
NATURE COMMUNICATIONS (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
The multifaceted contributions of mitochondria to cellular metabolism
Jessica B. Spinelli et al.
NATURE CELL BIOLOGY (2018)
The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2018)
Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
Marta Anna Kowalik et al.
FRONTIERS IN ONCOLOGY (2017)
MYC and tumor metabolism: chicken and egg
Francesca R. Dejure et al.
EMBO JOURNAL (2017)
CUE domain-containing protein 2 promotes the Warburg effect and tumorigenesis
Xiuying Zhong et al.
EMBO REPORTS (2017)
PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation
Ninel Azoitei et al.
MOLECULAR CANCER (2016)
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
Li Yu et al.
ONCOTARGET (2016)
TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo
Li-Hua Dong et al.
CIRCULATION RESEARCH (2015)
Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
Berengere Gobin et al.
PLOS ONE (2014)
The pentose phosphate pathway and cancer
Krushna C. Patra et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Regulation of the pentose phosphate pathway in cancer
Peng Jiang et al.
PROTEIN & CELL (2014)
Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
Krushna C. Patra et al.
CANCER CELL (2013)
Proliferation-Independent Control of Tumor Glycolysis by PDGFR-Mediated AKT Activation
Cong Ran et al.
CANCER RESEARCH (2013)
Desnutrin/ATGL Activates PPARδ to Promote Mitochondrial Function for Insulin Secretion in Islet β Cells
Tianyi Tang et al.
CELL METABOLISM (2013)
Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway
Vesselina G. Cooke et al.
CANCER CELL (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis
Sofia Konisti et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Peng Jiang et al.
NATURE CELL BIOLOGY (2011)
mTOR: A pathogenic signaling pathway in developmental brain malformations
Peter B. Crino
TRENDS IN MOLECULAR MEDICINE (2011)
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Chi V. Dang et al.
CLINICAL CANCER RESEARCH (2009)
Tumor suppressors and cell metabolism: a recipe for cancer growth
Russell G. Jones et al.
GENES & DEVELOPMENT (2009)
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
Tadahiko Kubo et al.
CANCER (2008)
Role of platelet-derived growth factors in physiology and medicine
Johanna Andrae et al.
GENES & DEVELOPMENT (2008)
Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling
R. Tsuchida et al.
ONCOGENE (2008)
Dysregulation of the TSC-mTOR pathway in human disease
K Inoki et al.
NATURE GENETICS (2005)
Share Paper
